IPP Investment GmbH is a focused investor in medtech ventures. We invest selectively in fields we know deeply, where we can add value efficiently if needed, not just financially but also through hands-on support in strategy, execution, and regulatory reality checks.

Investing in Startups, we strongly prefer companies that operate within the Easy13485 Makerspace. The reason is simple: it gives us confidence that the fundamentals of quality and regulatory compliance are in place from the start—reducing the risk of hidden regulatory gaps that can derail timelines, budgets, and valuations.

We encourage every Investor to read the Med-tech de Risking Guide. We experience a 0% failure Rate in our investments. Of course you do not win a marte with compliance, but you shure can lose it.

Our most important decision criterion is the team. We back founders who work in a pragmatic and goal-driven way: clear in communication, fast in decision-making, and willing to adapt when facts change, without losing sight of the objective. They understand regulatory requirements and take them seriously, but they don’t “fall in love” with regulation. Compliance is treated as a constraint to manage intelligently- so the company can move quickly, stay audit-ready, and deliver real value to patients and customers.